Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 46Unknown 14Terminated 13Active not recruiting 8Recruiting 7Withdrawn 4Enrolling by invitation 3Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 5Small Cell Lung Carcinoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3Head and Neck Neoplasms 3Gallbladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Myelodysplastic Syndromes 2Multiple Myeloma 2Lymphoma, Follicular 2Glioma 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1TNBC 1Stomatitis 1Stomach Neoplasms 1Squamous Intraepithelial Lesions 1Smoldering Multiple Myeloma 1Recurrence 1Parkinsonian Disorders 1Pancreatic Neoplasms 1Pancreatic Cancer Non-resectable 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Nasopharyngeal Neoplasms 1

Interventions

130-nm albumin-bound paclitaxel 2camrelizumab 1anlotinib 1S 1 (combination) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Enrolling by invitation × Gallbladder Neoplasms × Clear all
NCT07310069 2025-12-30

TRANSFORM-GBC

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Enrolling by invitation
44 enrolled
Gastrointestinal

Gallbladder Neoplasms

NCT06963060 2025-05-08

GALENT-BT

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Enrolling by invitation
44 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

NCT06901622 2025-03-30

Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma

The First Affiliated Hospital of Zhengzhou University

Phase 2 Enrolling by invitation
50 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡